Quadruple therapy with ecabet sodium, omeprazole, amoxicillin and metronidazole is effective for eradication of Helicobacter pylori after failure of first-line therapy (KDOG0201 Study)

Journal of Clinical Pharmacy and Therapeutics

Volumn 35, Issue 3, 2010, Pages 303-307

  Koizumi, W ^a   Tanabe, S ^a   Nakatani, K ^a   Ishido, K ^a   Nishimura, K ^a   Azuma, M ^a   Ae, T ^a   Sasaki, T ^a   Higuchi, K ^a   Katada, C ^a   Nakayama, N ^a   Saigenji, K ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Ecabet sodium; Eradication; Helicobacter pylori; Second line therapy

Indexed keywords

12 SULFODEHYDROABIETIC ACID; AMOXICILLIN; CARBON 13; CLARITHROMYCIN; LANSOPRAZOLE; METRONIDAZOLE; OMEPRAZOLE; UREA;

ABDOMINAL PAIN; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; DUODENUM ULCER; ERADICATION THERAPY; FEMALE; GASTRODUODENAL ULCER; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; NONHUMAN; PATIENT COMPLIANCE; PEPTIC ULCER; PRIMARY HEALTH CARE; SIDE EFFECT; STOMACH ULCER; TREATMENT RESPONSE;

ADULT; AGED; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; DITERPENES, ABIETANE; DRUG THERAPY, COMBINATION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; OMEPRAZOLE; PEPTIC ULCER; PILOT PROJECTS; TREATMENT OUTCOME;

EID: 77952197535     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2009.01092.x     Document Type: Article

References (20)

1. Shimoyama T, Fukuda S, Mikami T, Fukushi M, Munakata A (2004) Efficacy of metronidazole for the treatment of clarithromycin-resistant Helicobacter pylori infection in a Japanese population. Journal of Gastroenterology, 39, 927 930.
2. Isomoto H, Inoue K, Furusu H et al. (2003) High-dose rabeprazole- amoxicillin versus rabeprazole-amoxicillin-metronidazole as second-line treatment after failure of the Japanese standard regimen for Helicobacter pylori infection. Alimentary Pharmacology and Therapeutics, 18, 101 107.
3. Kawai T, Kawakami K, Takei K et al. (2005) Impact of efficacies of dual therapy and triple therapy using rabeprazole for the second-line eradication therapy of Helicobacter pylori in Japan. Gastroenterology, 128 (Suppl. 2 A 428.
4. Shirai N, Furuta T, Sugimoto M et al. (2005) Dual therapy with high-dose of rabeprazole and amoxicilline versus triple therapy with rabeprazole, amoxicillin and metronidazole as the second line therapy for the cure of H. pylori infection. Gastroenterology, 128 (Suppl. 2 A 430.
5. Kato T, Yamaoka Y, Kim JJ et al. (2000) Regional differences in metronidazole resistance and increasing clarithromycin resistance among Helicobacter pylori isolates from Japan. Antimicrobial Agents and Chemotherapy, 44, 2214 2216.
6. Torres J, Camorlinga-Ponce M, Pérez-Pérez G et al. (2001) Increasing multidrug resistance in Helicobacter pylori strains isolated from children and adults in Mexico. Journal of Clinical Microbiology, 39, 2677 2680.
7. Osato MS, Reddy R, Reddy SG, Penland RL, Malaty HM, Graham DY (2001) Pattern of primary resistance of Helicobacter pylori to metronidazole or clarithromycin in the United States. Archives of Internal Medicine, 161, 1217 1220.
8. Koizumi W, Tanabe S, Hibi K et al. (1998) A prospective randomized study of amoxicillin and omeprazole with and without metronidazole in the eradication treatment of Helicobacter pylori. Journal of Gastroenterology and Hepatology, 13, 301 304.
9. Kinoshita M, Kagami A, Iwasaki M et al. (1995) Adhesive effect of ecabet sodium in a porcine gastric ulcer model. Digestive Endscopy, 40, 661 667.
10. Ito Y, Nakamura S, Onoda Y, Sugawara Y, Takaiti O (1993) Effects of the new anti-ulcer drug ecabet sodium (TA-2711) on pepsin activity I. Inactivation of enzyme protein. Japanese Journal of Pharmacology, 62, 169 174. (Pubitemid 23218236)
11. Shibata K, Ito Y, Hongo A, Yasoshima A, Endo T, Ohashi M (1995) Bactericidal activity of a new antiulcer agent, ecabet sodium, against Helicobacter pylori under acidic conditions. Antimicrobial Agents and Chemotherapy, 6, 1295 1299.
12. Hayashi S, Sugiyama T, Yachi A, Yokota K, Hirai Y, Oguma K, Fujii N (1997) Effect of ecabet sodium on Helicobacter pylori adhesion to gastric epithelial cells. Journal of Gastroenterology, 32, 593 597.
13. Kim JM, Kim JS, Jung HC, Oh YK, Kim N, Song IS (2003) Inhibition of Helicobacter pylori-induced nuclear factor-kappa B activation and interleukin-8 gene expression by ecabet sodium in gastric epithelial cells. Helicobacter, 8, 542 553.
14. Shimoyama T, Fukuda S, Liu Q, Nakaji S, Munakata A, Sugawara K (2001) Ecabet sodium inhibits the ability of Helicobacter pylori to induce neutrophil production of reactive oxygen species and interleukin-8. Journal of Gastroenterology, 36, 153 157.
15. Koizumi W, Tanabe S, Imaizumi H et al. (2003) Inhibition of peptic ulcer relapse by ranitidine and ecabet independently of eradication of Helicobacter pylori: a prospective, controlled study vs. ranitidine. Hepato-Gastroenterology, 50, 577 581.
16. Kim HW, Kim GH, Cheong JY et al. (2008) H. pylori eradication: a randomized prospective study of triple therapy with or without ecabet sodium. World Journal of Gastroenterology, 14, 908 912.
17. Kagaya H, Kato M, Komatsu Y et al. (2000) High-dose ecabet sodium improves the eradication of Helicobacter pylori in dual therapy with lansoprazole and amoxicillin. Alimentary Pharmacology and Therapeutics, 14, 1523 1527.
18. Ohkusa T, Takashimizu I, Fujiki K et al. (1998) Prospective evaluation of a new anti-ulcer agent, ecabet sodium, for the treatment of Helicobacter pylori infection. Alimentary Pharmacology and Therapeutics, 12, 457 461.
19. Furuta T, Kodaira C, Nishino M, Yamada M, Sugimoto M (2008) Effect of quadruple therapy with rabeprazole, amoxicillin, metronidazole, and ecabet sodium as third-line treatment for H. pylori infection. 14th Annual Meeting of Japanese Society for Helicobacter, Kobe, 119 (abstract).
20. Malfertheiner P, Megraud F, O'Morani C et al. (2007) Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut, 56, 772 781. (Pubitemid 46854190)